TP53 and oral cavity squamous cell carcinoma: In oral squamous cell carcinoma (OSCC), MG-132 was found to block the degradation of p53 by UPP and induced apoptosis by nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κb) pathway downregulation [29].